Reumatología

2014

1. Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patients

   Rheumatology (Oxford, England), Vol. 53, Núm. 12, pp. 2223-2231

2. Canakinumab for gout: A specific, patient-profiled indication

   Expert Review of Clinical Immunology, Vol. 10, Núm. 3, pp. 339-347

3. Clinical manifestations and diagnosis of gout

   Rheumatic Disease Clinics of North America, Vol. 40, Núm. 2, pp. 193-206

4. Crystal arthritis: Environment and genetics in gout: A maze for clinicians?

   Nature Reviews Rheumatology

5. Cytokine gene considerations in giant cell arteritis: IL10 promoter polymorphisms and a review of the literature

   Clinical Reviews in Allergy and Immunology, Vol. 47, Núm. 1, pp. 56-64

6. Detection of synovitis by ultrasonography in clinically inactive juvenile idiopathic arthritis on and off medication

   Clinical and Experimental Rheumatology, Vol. 32, Núm. 4, pp. 597-603

7. Diagnosis of gout

   Managing Gout in Primary Care (Springer Healthcare), pp. 25-39

8. Disease overview

   Managing Gout in Primary Care (Springer Healthcare), pp. 1-12

9. Estándares de calidad en una Unidad de Hospitalización de Día reumatológica. Propuesta del Grupo de Trabajo de Hospitales de Día de la Sociedad Española de Reumatología

   Reumatologia Clinica, Vol. 10, Núm. 6, pp. 380-388

10. Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: An international collaboration

    Pediatric Rheumatology, Vol. 12, Núm. 1

11. Improving cardiovascular and renal outcomes in gout: What should we target?

    Nature Reviews Rheumatology, Vol. 10, Núm. 11, pp. 654-661

12. Infección protésica por Mycobacterium tuberculosis en paciente con artritis reumatoide: Reporte de un caso y revisión bibliográfica

    Reumatologia Clinica

13. Influence of interleukin 10 promoter polymorphisms in polymyalgia rheumatica: Disease susceptibility and functional consequences

    Clinical and Experimental Rheumatology, Vol. 32, Núm. 4, pp. 484-489

14. Macrophage activation syndrome as a severe manifestation of adult's Sitll's disease. Hemophagocytic cells in ascites

    Reumatologia Clinica

15. Managing gout in primary care

    Springer Healthcare, pp. 1-69

16. Osteomalacia inducida por adefovir en paciente con hepatitis B

    Reumatologia Clinica, Vol. 10, Núm. 2, pp. 120-121

17. Physiopathology of gout

    Managing Gout in Primary Care (Springer Healthcare), pp. 13-24

18. Polyostotic fibrous displasia: A case report

    Reumatologia Clinica, Vol. 10, Núm. 6, pp. 413-415

19. Prevention and treatment of inflammation in gout

    Managing Gout in Primary Care (Springer Healthcare), pp. 53-66

20. Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): A large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia

    BMJ Open, Vol. 4, Núm. 7